Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Program: Scientific Session
General Topic: Clinical

Controversies in the Treatment of Knee Osteoarthritis: Do Alternative Therapies Actually Work?

Sunday, October 26, 2025
10:30 AM – 11:30 AM Central Time

    Moderator(s)

  • C. Thomas Appleton, MD, PhD, FRCPC

    The University of Western Ontario
    London, Ontario, Canada

    Disclosure(s): AbbVie/Abbott: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • MJ

    Matlock Jeffries, MD, FACP, FACR

    Oklahoma Medical Research Foundation
    Oklahoma City, Oklahoma, United States

    Disclosure information not submitted.

    • Session Coordinator(s)

  • MJ

    Matlock Jeffries, MD, FACP, FACR

    Oklahoma Medical Research Foundation
    Oklahoma City, Oklahoma, United States

    Disclosure information not submitted.

Are new/alternative therapies for knee osteoarthritis (OA) ready for prime time?

Learning Objectives:

  • Compare the effectiveness of standard-of-care intraarticular injectables with PRP and stem cell therapy in knee OA
  • Inspect the evidence for low-dose radiation and geniculate artery ablation for knee OA
  • Construct a treatment plan for complicated knee OA patients that do not respond to conventional therapy

Presentations:

  • 10:30 AM – 11:00 AM Central Time
    Platelet-Rich Plasma and Stem Cell Therapy for Knee Osteoarthritis: Do They Work?

    Speaker: C. Thomas Appleton, MD, PhD, FRCPC – The University of Western Ontario

  • 11:00 AM – 11:30 AM Central Time
    Unconventional Nonpharmacological Therapies for Knee Osteoarthritis: Genicular Nerve Ablation, Genicular Artery Embolization, and Low-Dose Radiation

    Speaker: Lisa Mandl, MD, MPH – Hospital for Special Surgery